BOSTON SCIENTIFIC CORP
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $20.1B | $16.7B | $14.2B | $12.7B | $11.9B |
| Gross profit | $13.9B | $11.5B | $9.9B | $8.7B | $8.2B |
| Operating income | $3.6B | $2.6B | $2.3B | $1.6B | $1.2B |
| Operating expenses | $10.2B | $8.9B | $7.6B | $7.1B | $7.0B |
| Cost of revenue | $6.2B | $5.3B | $4.3B | $4.0B | $3.7B |
| Cash from operations | $4.5B | $3.4B | $2.5B | $1.5B | $1.9B |
| Capital expenditure | $876.0M | $790.0M | $711.0M | $588.0M | $554.0M |
| Free cash flow | $3.7B | $2.6B | $1.8B | $938.0M | $1.3B |
| Share repurchases | — | — | — | $0 | $0 |
| Impairments | $46.0M | $386.0M | $58.0M | $0 | $0 |
| Total assets | $43.7B | $39.4B | $35.1B | $32.5B | $32.2B |
| Total debt | — | $10.7B | $9.1B | $8.9B | $9.1B |
Shares outstanding 1.5B · Free float 99.8%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.